Notice to Extend PAR-18-942 Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)

Notice Number: NOT-MH-18-061

Key Dates
Release Date: October 23, 2018

Related Announcements
PAR-18-942

Issued by
National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to extend PAR-18-942, Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional).

Part 1. Overview Information

Key Dates

Currently reads:

Application Due Date(s) November 26, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s) Not Applicable

Scientific Merit Review February 2019

Advisory Council Review May 2019

Earliest Start Date July 2019

Expiration Date November 27, 2018

Modified to read:

Application Due Date(s) November 26, 2018, and then standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s) Not Applicable

Scientific Merit Review February 2019 and then standard dates apply

Advisory Council Review May 2019 and then standard dates apply

Earliest Start Date July 2019

Expiration Date September 8, 2021

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

David McMullen, M.D.
National Institute of Mental Health (NIMH)
Telephone: 301-451-0180
Email: david.mcmullen@nih.gov